Cargando…
A LEX Friedrich
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445253/ https://www.ncbi.nlm.nih.gov/pubmed/34548841 http://dx.doi.org/10.1007/s41187-021-1073-z |
_version_ | 1784568611447242752 |
---|---|
author | Kiers, Bart |
author_facet | Kiers, Bart |
author_sort | Kiers, Bart |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8445253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-84452532021-09-17 A LEX Friedrich Kiers, Bart Zorgvisie Interview Bohn Stafleu van Loghum 2021-09-24 2021 /pmc/articles/PMC8445253/ /pubmed/34548841 http://dx.doi.org/10.1007/s41187-021-1073-z Text en © Bohn Stafleu van Loghum is een imprint van Springer Media B.V., onderdeel van Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Interview Kiers, Bart A LEX Friedrich |
title | A LEX Friedrich |
title_full | A LEX Friedrich |
title_fullStr | A LEX Friedrich |
title_full_unstemmed | A LEX Friedrich |
title_short | A LEX Friedrich |
title_sort | lex friedrich |
topic | Interview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445253/ https://www.ncbi.nlm.nih.gov/pubmed/34548841 http://dx.doi.org/10.1007/s41187-021-1073-z |
work_keys_str_mv | AT kiersbart alexfriedrich AT kiersbart lexfriedrich |